Influenza News and Research

Latest Influenza News and Research

New treatment for toxic shock syndrome

Researchers at the University of Minnesota and the University of Illinois at Urbana-Champaign have developed a new therapeutic that neutralizes Toxic Shock Syndrome (TSS) more effectively than other treatments.

23 May 2007

New strategy to inoculate medical staff in a pandemic situation

Community preparedness for a bioterrorism attack or influenza outbreak has been the focus of much interest and effort in recent years.

22 May 2007

Healthcare worker response to disaster conditions

When disaster strikes, getting care to the victims is at the top of everyone's attention. But who will provide that care" In two studies to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, researchers examined the factors that might affect whether healthcare workers and support staff would report to work during a disaster.

17 May 2007

Bird flu, WHO and Indonesia

The World Health Organization (WHO) has announced that Indonesia will no longer require an outside laboratory to confirm test results for bird flu.

16 May 2007

FluMist gets FDA green light

The Food and Drug Administration (FDA) in the United States says FluMist, an influenza vaccine made by MedImmune appears to be safe for young children even though the influenza vaccine is still under review.

15 May 2007

New host species for avian influenza A virus (H5N1)

In a new study published online in the open-access journal PLoS Pathogens, Dr. Vincent J. Munster, of Erasmus Medical Center, Rotterdam, and colleagues identify new host species for avian influenza A virus (H5N1) and provide important information on the distinctions between the ecology and epidemiology of various global strains of the virus.

11 May 2007

Dealing with a flu pandemic in the UK

Giving local authorities responsibility for implementing pandemic flu plans may not be the best policy, says a senior public health doctor in this week's BMJ.

11 May 2007

Low frequency of resistance to Tamiflu confirmed

New data published by the World Health Organisation (WHO) has confirmed a low frequency of resistance to Tamiflu (oseltamivir) over 3 influenza seasons (2003:2006).

10 May 2007

FluForecast trial predicted high human H5N1 mortality in Indonesia

When H5N1 was thought to be quiescent in 2006, in a prospective open trial, FluForecast, a software program which measures virus gene proteins, predicted high human mortality H5N1 outbreaks to come.

10 May 2007

Predicting the next pandemic

In planning for a future influenza pandemic, most experts agree that two things are known for certain, there will be another pandemic someday, and nobody can predict when.

9 May 2007

Hydrogel to tackle H5N1

Influenza virus H5N1, which caused the recent outbreak of avian flu, may have a new enemy.

9 May 2007

FluMist may help reduce the burden of seasonal influenza

MedImmune, Inc. has announced research results showing that use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) in daycare and school settings may help reduce the burden of seasonal influenza.

9 May 2007

Face masks offer little protection from bird flu

According to the U.S. Centers for Disease Control and Prevention the mass wearing of surgical face masks would do little to reduce the rate of infection in the event of an influenza pandemic.

7 May 2007

US control strategies may make flu epidemics worse

Regular as clockwork, the flu arrives every year. And, according to the national Centers for Disease Control and Prevention, 5 to 20 percent of the U.S. population on average will come down with it. About 36,000 people will die.

4 May 2007

Study shows effectiveness of Peramivir in mouse model of H5N1 virus infection

BioCryst Pharmaceuticals has announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam).

4 May 2007

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2

LigoCyte Pharmaceuticals has presented preclinical data showing that immunization with their influenza virus-like particles (VLPs) induced heterosubtypic protection in a virus challenge study.

4 May 2007

Child infections are an increasing concern in affluent countries

Dr Deborah Lehmann, who leads infectious diseases research at the Telethon Institute for Child Health Research, said the findings show that infection is an increasing concern in affluent countries.

4 May 2007

Peramivir shows promise for H5N1 protection

The antiviral drug peramivir might offer humans significant protection during a pandemic of the avian influenza virus H5N1, according to results of mouse studies conducted by investigators at St. Jude Children's Research Hospital.

2 May 2007

Protecting Americans against a smallpox outbreak

In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question.

1 May 2007

Google maps used to track avian flu spread

An interactive "supermap" that portrays the mutations and spread of the avian flu around the globe over time should help researchers and policy makers better understand the virus and anticipate further outbreaks, according to a new study involving University of Colorado at Boulder and Ohio State University researchers.

1 May 2007